EssexBio

Read more
CEO Avatar

Managing Director

Fang Haizhou

CEO Approval Rating

70/100

Founded:

2000

Status:

PublicIndependent CompanyHong Kong Stock Exchange01061

Annual Revenue
$115.1M
Employees
1,024
Headquarters

ESSEXBIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

EssexBio's company profile
CEO Avatar

Fang Haizhou

Managing Director

70/100
1,024
$0
$115.1M
View Profile
1
EssexBio's Competitor - Techpool logo
Henry Lee's photo - CEO of Techpool

Henry Lee

CEO

69/100
$20.5M
View Profile
2
EssexBio's Competitor - CBPO logo
Joseph Chow's photo - CEO of CBPO

Joseph Chow

CEO

90/100
2,269
- -
$536.5M
View Profile
3
EssexBio's Competitor - Frontier Biotech logo
CJ Wang's photo - CEO of Frontier Biotech

CJ Wang

CEO

70/100
$43M
View Profile
4
EssexBio's Competitor - Trusted Tablets logo
CEO Avatar

CEO

- -
19
- -
$1.2M
View Profile

Missing a competitor? Contribute!

Techpool is one of EssexBio's top rivals. Techpool was founded in Guangzhou, Guangdong Province} in 1993. Like EssexBio, Techpool also competes in the Pharmaceuticals space. Compared to EssexBio, Techpool generates $ less revenue.

CBPO is EssexBio's #2 competitor. CBPO was founded in 2002, and is headquartered in Chaoyang District, Beijing Municipality. Like EssexBio, CBPO also operates in the Pharmaceuticals space. CBPO generates $421.4M more revenue vs. EssexBio.

Frontier Biotech is a top competitor of EssexBio. Frontier Biotech's headquarters is in Nanjing, Jiangsu Province, and was founded in 2002. Like EssexBio, Frontier Biotech also works within the Pharmaceuticals sector. Frontier Biotech generates NaN% of EssexBio's revenue.

EssexBio Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$115.1M

EssexBio's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 217.6M. Over the last four quarters, EssexBio's revenue has decreased by 0%. Specifically, in Q4 2017's revenue was $115.1M; in Q3 2017, it was $115.1M; in Q2 2017, it was $115.1M; in Q1 2017, EssexBio's revenue was $115.1M.

EssexBio Acquisitions

No recent acquisitions found related to EssexBio

EssexBio Funding History

No recent funding data found related to EssexBio

EssexBio Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

X-Zell is a biotechnology company that develops a tCEC-based blood test for the early detection of cancer.
$4M
Oct 14, 2020
-
$3.5M
Apr 05, 2016
-

These are all the companies that EssexBio has invested in. EssexBio has invested 2 companies and its latest investment was X-ZELL in Oct 14,. X-Zell is a biotechnology company that develops a tCEC-based blood test for the early detection of cancer.

EssexBio News

February 24, 2021MarketScreener

INSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - POSITIVE OUTCOME OF U.S. FDA SECOND PHASE 3 CLINICAL TRIAL IN DRY EYE DISEASE

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
October 21, 2020The Center for Biosimilar

Henlius Inks Global Bevacizumab Biosimilar Distribution Deal

Shanghai Henlius Biotech will share development and distribution of its bevacizumab biosimilar candid... See more »
September 18, 2020MarketScreener

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

(marketscreener.com) LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION With effect from 19 September 2020... See more »
December 27, 2019MarketScreener

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE SINGLE-DOSE BEIFUSHU EYE DROPS IN THE PRC

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
December 12, 2019MarketScreener

INSIDE INFORMATION UPDATES ON U.S. FDA SECOND PHASE 3 CLINICAL TRIAL RELATING TO DRY EYE DISEASE

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
August 21, 2019MarketScreener

Admission of Product to the PRC National Drug List for Reimbursement Beifuxin Newly Listed and the Other Three Products Remain on the List

(marketscreener.com) Press release 21 Aug 2019 ...http://www.marketscreener.com/ESSEX-BIO-TECHNOLOGY-... See more »
August 13, 2019MarketScreener

Profit-After-Tax Up 31% to HK$ 129 million, Net Gain of HK$ 18 million from Partial Divestment of MeiraGTx Recorded in Other Comprehensive Income

(marketscreener.com) Press release 12 Aug 2019 ...http://www.marketscreener.com/ESSEX-BIO-TECHNOLOGY-... See more »

EssexBio Press Releases

May 16, 2015PR-INSIDE.COM

Essex Bio-Technology Limited (1061) - Financial and Strategic SWOT Analysis Review - New Report Available

(PR-inside.com) Essex Bio-Technology Limited (Essex) is a biopharmaceutical company. The company manu... See more »

Social Media

EssexBio Headquarters

168-200 Connaught Road Central Room 2818,China Merchants Tower,Shun Tak Centre

Hong Kong, Other

852-2587-7838

Driving Directions »

Trending Companies

EssexBio Summary

ABOUT

Overview

Zhuhai Essex Bio-Pharmaceutical Company researches, develops, produces, and distributes genetically engineered drugs. EssexBio was founded in 2000. EssexBio's headquarters is located in Hong Kong, Other, HK . EssexBio's Managing Director, Fang Haizho...

CEO

EssexBio's Managing Director, Fang Haizhou, currently has an approval rating of 70%. EssexBio's primary competitors are Techpool, CBPO & Frontier Biotech.

Frequently Asked Questions about EssexBio

  1. When was EssexBio founded?

    EssexBio was founded in 2000
  2. Who is EssexBio's CEO?

    EssexBio's CEO is Fang Haizhou
  3. How much revenue does EssexBio generate?

    EssexBio generates $115.1M in revenue
  4. How much funding does EssexBio have?

    EssexBio has historically raised $0 in funding
  5. Where is EssexBio's headquarters?

    EssexBio's headquarters is in Hong Kong Other, HK
  1. How many employees does EssexBio have?

    EssexBio has 1,024 employees
  2. What sector does EssexBio operate in?

    EssexBio is in Pharmaceuticals
  3. Who are EssexBio's competitors?

    EssexBio's top competitors are Techpool, CBPO, Frontier Biotech
  4. Who has EssexBio invested in?

    EssexBio's has invested in companies such as X-ZELL, Abpro Therapeutics